Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Opioid-Related Disorders × Olanzapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 5 Nausea 5 Neoplasms 4 Hematologic Neoplasms 4 Anorexia 3 Breast Neoplasms 2 Testicular Neoplasms 1 Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy 1 Prosthesis Failure 1 Opioid-Related Disorders 1 Nutrition Disorders 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Gynecologic Cancer 1 Cachexia 1 Advanced Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06200181 2026-02-13

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

M.D. Anderson Cancer Center

Phase 3 Recruiting

Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡